Regeneron stock rose early Tuesday on a strong fourth-quarter report that included in-line sales of eye drug Eylea.
The post Regeneron Advances On Fourth-Quarter Beat As Eylea Meets Expectations appeared first on Investor’s Business Daily.
Regeneron stock rose early Tuesday on a strong fourth-quarter report that included in-line sales of eye drug Eylea.
The post Regeneron Advances On Fourth-Quarter Beat As Eylea Meets Expectations appeared first on Investor’s Business Daily.